Address :FIVE MOORE DRIVE RESEARCH TRIANGLE PARK, NC, 27709-3398 UNITED STATES | |||
Status : A | Type : A | Woman Owned : N | Business Type : N |
Business Size : E | Primary Business : J | CAO Code : S5111A | ADP Code : HQ0338 |
Part No | Item Name | Manufacturer | NSN | QTY | RFQ |
---|---|---|---|---|---|
00173024975 | digoxin tablets usp | glaxowellcome | 6505-00-616-7898 | Avl | RFQ |
NCD00173-0434-00 | ceftazidime for injection usp | glaxowellcome | 6505-01-285-7473 | Avl | RFQ |
NDC00173-0230-44 | digoxin immune fab for injection | glaxowellcome | 6505-01-273-1798 | Avl | RFQ |
NDC00173-0242-55 | digoxin tablets usp | glaxowellcome | 6505-00-449-0321 | Avl | RFQ |
NDC00173-0242-75 | digoxin tablets usp | glaxowellcome | 6505-00-481-1802 | Avl | RFQ |
NDC00173-0249-80 | digoxin tablets usp | glaxowellcome | 6505-01-153-3236 | Avl | RFQ |
NDC00173-0260-10 | digoxin injection u | glaxowellcome | 6505-00-531-7761 | Avl | RFQ |
NDC00173-0272-55 | digoxin capsules | glaxowellcome | 6505-01-165-1484 | Avl | RFQ |
NDC00173-0273-22 | vitamin b complex a | glaxowellcome | 6505-00-549-3856 | Avl | RFQ |
NDC00173-0281-43 | ethaverine hydrochl | glaxowellcome | 6505-00-767-5675 | Avl | RFQ |
NDC00173-0312-88 | beclometasone dipropionate inhalation aerosol | glaxowellcome | 6505-01-240-0588 | Avl | RFQ |
NDC00173-0346-47 | labetalol hydrochloride tablets usp | glaxowellcome | 6505-01-218-7436 | Avl | RFQ |
NDC00173-0347-47 | labetalol hydrochloride tablets usp | glaxowellcome | 6505-01-319-5117 | Avl | RFQ |
NDC00173-0348-47 | labetalol hydrochloride tablets usp | glaxowellcome | 6505-01-319-5118 | Avl | RFQ |
NDC00173-0353-32 | cefuroxime sodium usp | glaxowellcome | 6505-01-238-5629 | Avl | RFQ |
NDC00173-0356-32 | cefuroxime sodium usp | glaxowellcome | 6505-01-209-1205 | Avl | RFQ |
NDC00173-0376-01 | clobetasol propionate lotion | glaxowellcome | 6505-01-310-8332 | Avl | RFQ |
NDC00173-0380-32 | ceftazidime for inj | glaxowellcome | 6505-01-231-4806 | Avl | RFQ |
NDC00173-0401-00 | alclometasone dipropionate cream usp | glaxowellcome | 6505-01-315-5328 | Avl | RFQ |
NDC00173-0401-01 | alclometasone dipropionate cream usp | glaxowellcome | 6505-01-314-7931 | Avl | RFQ |
NDC00173-0401-06 | alclometasone dipropionate cream usp | glaxowellcome | 6505-01-387-6731 | Avl | RFQ |
NDC00173-0402-00 | alclometasone dipropionate ointment usp | glaxowellcome | 6505-01-315-5329 | Avl | RFQ |
NDC00173-0402-01 | alclometasone dipropionate ointment usp | glaxowellcome | 6505-01-315-5327 | Avl | RFQ |
NDC00173-0402-06 | alclometasone dipropionate ointment usp | glaxowellcome | 6505-01-387-6732 | Avl | RFQ |
NDC00173-0417-00 | ceftazidime for injection usp | glaxowellcome | 6505-01-336-6183 | Avl | RFQ |
NDC00173-0423-01 | oxiconazole nitrate | glaxowellcome | 6505-01-315-5326 | Avl | RFQ |
NDC00173-0423-04 | oxiconazole nitrate cream | glaxowellcome | 6505-01-387-6734 | Avl | RFQ |
NDC00173-0424-00 | cefuroxime sodium i | glaxowellcome | 6505-01-317-1109 | Avl | RFQ |
NDC00173-0431-00 | fluticasone propionate ointment | glaxowellcome | 6505-01-341-9962 | Avl | RFQ |
NDC00173-0432-01 | clobetasol propionate lotion | glaxowellcome | 6505-01-325-6587 | Avl | RFQ |
NDC00173-0446-00 | ondansetron hydrochloride tablets | glaxowellcome | 6505-01-374-5866 | Avl | RFQ |
NDC00173-0446-02 | ondansetron hydrochloride tablets | glaxowellcome | 6505-01-374-5867 | Avl | RFQ |
NDC00173-0447-04 | ondansetron hydrochloride tablets | glaxowellcome | 6505-01-374-5868 | Avl | RFQ |
NDC00173-0448-01 | oxiconazole nitrate lotion | glaxowellcome | 6505-01-387-7581 | Avl | RFQ |
NDC00173-0461-00 | ondansetron hydrochloride in dextrose injection | glaxowellcome | 6505-01-417-9964 | Avl | RFQ |
NDC00173-0543-01 | cisatracurium besylate injection | glaxowellcome | 6505-01-434-0941 | Avl | RFQ |
NDC00173-0595-02 | lamivudine and zidovudine tablets | glaxowellcome | 6505-01-518-1648 | Avl | RFQ |
NDC00173-0656-01 | vinorelbine tartrate injection | glaxowellcome | 6505-01-408-7544 | Avl | RFQ |
NDC00173-0695-00 | fluticasone propionate salmeterol xinafoate inhale | glaxowellcome | 6505-01-504-9481 | Avl | RFQ |
NDC00173-0705-44 | mivacurium chloride injection | glaxowellcome | 6505-01-356-4834 | Avl | RFQ |
NDC00173-0713-25 | busulfan tablets us | glaxowellcome | 6505-00-660-1634 | Avl | RFQ |
NDC00173-0880-25 | thioguanine tablets usp | glaxowellcome | 6505-01-153-3394 | Avl | RFQ |
NDC00173-0952-01 | acyclovir sodium sterile | glaxowellcome | 6505-01-324-9307 | Avl | RFQ |
NDC19515-0891-11 | influenza virus vaccine usp | glaxowellcome | 6505-01-627-9125 | Avl | RFQ |
NDC19515-0893-07 | influenza virus vaccine usp | glaxowellcome | 6505-01-627-2699 | Avl | RFQ |
NDC19515-0894-52 | influenza virus vaccine usp | glaxowellcome | 6505-01-627-9368 | Avl | RFQ |
NDC58160-0857-16 | hepatitis b virus vaccine inactivated modified | glaxowellcome | 6505-01-492-5825 | Avl | RFQ |
NDC58160-0901-52 | influenza virus vac | glaxowellcome | 6505-01-627-2769 | Avl | RFQ |
NDC60976-0346-47 | labetalol hydrochloride tablets usp | glaxowellcome | 6505-01-218-7436 | Avl | RFQ |
NDC60976-0348-47 | labetalol hydrochloride tablets usp | glaxowellcome | 6505-01-319-5118 | Avl | RFQ |
All Orders are Fulfilled in the U.S.A.
All shipments must comply with U.S.A export laws.
No exceptions.
The only independent distributor
with a NO CHINA SOURCING Pledge
“We Proudly Support Intrepid Fallen Heroes Fund that serves United States Military Personal experiencing the Invisible Wounds of War : Traumatic Brain Injury (TBI) and Post Traumatic Stress (PTS). Please visit website (www.fallenheroesfund.org) and help in their valiant effort”.
Don’t forget That We offer 24/7 Service, Competitive Prices, and Fast Deliveries. We Hope You'll Make Us Your One-Stop Purchasing Solution!
Request for Quote